
Deep Origin is a biotechnology company that accelerates and de-risks drug discovery by combining molecular physics with AI-driven acceleration. Their flagship product, Balto AI, is a no-code AI assistant that simplifies complex molecular simulations and drug discovery workflows, enabling scientists without computational expertise to perform high-accuracy ligand docking, molecular profiling, and protein analysis. The company offers both an intuitive platform and code-based API access for computational chemists, integrating data from major chemical and biological databases. Deep Origin's business model includes partnerships and software licensing, focusing on reducing time, cost, and risk in preclinical drug discovery through physics-based AI and machine learning. Their team comprises experts in computational science, medicinal chemistry, physics, and biology, positioning them as innovators in the life sciences R&D market.

Deep Origin is a biotechnology company that accelerates and de-risks drug discovery by combining molecular physics with AI-driven acceleration. Their flagship product, Balto AI, is a no-code AI assistant that simplifies complex molecular simulations and drug discovery workflows, enabling scientists without computational expertise to perform high-accuracy ligand docking, molecular profiling, and protein analysis. The company offers both an intuitive platform and code-based API access for computational chemists, integrating data from major chemical and biological databases. Deep Origin's business model includes partnerships and software licensing, focusing on reducing time, cost, and risk in preclinical drug discovery through physics-based AI and machine learning. Their team comprises experts in computational science, medicinal chemistry, physics, and biology, positioning them as innovators in the life sciences R&D market.